Shopping Cart
- Remove All
- Your shopping cart is currently empty
Narlaprevir is an effective, selective, and orally bioavailable NS3 protease inhibitor(Ki=6 nM; EC90=40 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | 198 € | 5 days | |
25 mg | Inquiry | 10-14 weeks |
Description | Narlaprevir is an effective, selective, and orally bioavailable NS3 protease inhibitor(Ki=6 nM; EC90=40 nM). |
Targets&IC50 | Ketoamide:7 nM (Ki), NS3 protease:40 nM (EC90), NS3 protease:6 nM (Ki), Replicon RNA:40 nM (EC90) |
In vitro | Narlaprevir administration resulted in a robust HCV-RNA decline and high SVR rates when followed by standard of care in both treatment-experienced and treatment-naive HCV genotype 1-infected patients. HCV Narlaprevir is a potent inhibitor of the hepatitis C virus (HCV) nonstructural protein 3 serine protease that is primarily metabolized by the cytochrome P450-3A4 system. |
Alias | SCH 900518 |
Molecular Weight | 707.96 |
Formula | C36H61N5O7S |
Cas No. | 865466-24-6 |
Relative Density. | 1.21 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (70.63 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.